Banks - Regional
Compare Stocks
5 / 10Stock Comparison
FRME vs IBCP vs MBWM vs FFIN vs CBSH
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
FRME vs IBCP vs MBWM vs FFIN vs CBSH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $2.57B | $699M | $898M | $4.61B | $7.71B |
| Revenue (TTM) | $1.05B | $315M | $372M | $739M | $2.14B |
| Net Income (TTM) | $226M | $69M | $89M | $243M | $566M |
| Gross Margin | 61.0% | 69.6% | 64.0% | 70.8% | 80.0% |
| Operating Margin | 24.7% | 25.8% | 27.5% | 36.8% | 34.2% |
| Forward P/E | 11.1x | 9.6x | 9.5x | 15.9x | 13.0x |
| Total Debt | $1000M | $117M | $826M | $197M | $3.00B |
| Cash & Equiv. | $84M | $52M | $473M | $763M | $803M |
FRME vs IBCP vs MBWM vs FFIN vs CBSH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| First Merchants Cor… (FRME) | 100 | 144.4 | +44.4% |
| Independent Bank Co… (IBCP) | 100 | 245.7 | +145.7% |
| Mercantile Bank Cor… (MBWM) | 100 | 226.7 | +126.7% |
| First Financial Ban… (FFIN) | 100 | 105.7 | +5.7% |
| Commerce Bancshares… (CBSH) | 100 | 105.1 | +5.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FRME vs IBCP vs MBWM vs FFIN vs CBSH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FRME ranks third and is worth considering specifically for income & stability.
- Dividend streak 14 yrs, beta 0.95, yield 3.5%
- 3.5% yield, 14-year raise streak, vs FFIN's 2.2%
IBCP is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 184.6% 10Y total return vs MBWM's 178.2%
- Lower volatility, beta 0.83, Low D/E 23.2%, current ratio 370.62x
- Beta 0.83, yield 3.0%, current ratio 370.62x
MBWM is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.63 vs FFIN's 3.05
- Lower P/E (9.5x vs 13.0x), PEG 0.63 vs 1.15
- +23.6% vs CBSH's -13.9%
FFIN carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 18.8%, EPS growth 12.2%
- 18.8% NII/revenue growth vs FRME's -0.3%
- Efficiency ratio 0.3% vs CBSH's 0.5% (lower = leaner)
- Efficiency ratio 0.3% vs CBSH's 0.5%
CBSH is the clearest fit if your priority is bank quality.
- NIM 3.4% vs FRME's 2.8%
- Beta 0.70 vs FFIN's 0.95
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.8% NII/revenue growth vs FRME's -0.3% | |
| Value | Lower P/E (9.5x vs 13.0x), PEG 0.63 vs 1.15 | |
| Quality / Margins | Efficiency ratio 0.3% vs CBSH's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.70 vs FFIN's 0.95 | |
| Dividends | 3.5% yield, 14-year raise streak, vs FFIN's 2.2% | |
| Momentum (1Y) | +23.6% vs CBSH's -13.9% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs CBSH's 0.5% |
FRME vs IBCP vs MBWM vs FFIN vs CBSH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FRME vs IBCP vs MBWM vs FFIN vs CBSH — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FFIN leads in 2 of 6 categories
MBWM leads 1 • FRME leads 1 • IBCP leads 0 • CBSH leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FFIN leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CBSH is the larger business by revenue, generating $2.1B annually — 6.8x IBCP's $315M. FFIN is the more profitable business, keeping 30.2% of every revenue dollar as net income compared to FRME's 21.5%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $315M | $372M | $739M | $2.1B |
| EBITDAEarnings before interest/tax | $289M | $89M | $107M | $310M | $796M |
| Net IncomeAfter-tax profit | $226M | $69M | $89M | $243M | $566M |
| Free Cash FlowCash after capex | $284M | $70M | $11M | $290M | $570M |
| Gross MarginGross profit ÷ Revenue | +61.0% | +69.6% | +64.0% | +70.8% | +80.0% |
| Operating MarginEBIT ÷ Revenue | +24.7% | +25.8% | +27.5% | +36.8% | +34.2% |
| Net MarginNet income ÷ Revenue | +21.5% | +21.7% | +23.9% | +30.2% | +26.5% |
| FCF MarginFCF ÷ Revenue | +27.0% | +22.2% | +3.0% | +39.6% | +27.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -10.0% | +2.3% | +14.8% | -7.7% | +1.0% |
Valuation Metrics
MBWM leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 9.5x trailing earnings, MBWM trades at a 54% valuation discount to FFIN's 20.8x P/E. Adjusting for growth (PEG ratio), MBWM offers better value at 0.63x vs FFIN's 3.98x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.6B | $699M | $898M | $4.6B | $7.7B |
| Enterprise ValueMkt cap + debt − cash | $3.5B | $764M | $1.3B | $4.0B | $9.9B |
| Trailing P/EPrice ÷ TTM EPS | 10.44x | 10.38x | 9.53x | 20.76x | 12.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.10x | 9.56x | 9.54x | 15.92x | 13.01x |
| PEG RatioP/E ÷ EPS growth rate | 1.45x | 1.97x | 0.63x | 3.98x | 1.14x |
| EV / EBITDAEnterprise value multiple | 12.06x | 9.39x | 11.75x | 14.17x | 12.87x |
| Price / SalesMarket cap ÷ Revenue | 2.44x | 2.22x | 2.42x | 6.23x | 3.60x |
| Price / BookPrice ÷ Book value/share | 0.95x | 1.41x | 1.17x | 2.89x | 1.91x |
| Price / FCFMarket cap ÷ FCF | 9.04x | 9.96x | 80.15x | 15.73x | 13.01x |
Profitability & Efficiency
FFIN leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CBSH delivers a 15.3% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $9 for FRME. FFIN carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to MBWM's 1.14x. On the Piotroski fundamental quality scale (0–9), FRME scores 8/9 vs MBWM's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.5% | +14.2% | +13.5% | +13.3% | +15.3% |
| ROA (TTM)Return on assets | +1.2% | +1.3% | +1.4% | +1.6% | +1.7% |
| ROICReturn on invested capital | +5.6% | +10.2% | +5.5% | +11.0% | +8.4% |
| ROCEReturn on capital employed | +3.5% | +2.6% | +8.0% | +16.0% | +2.3% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 8 | 4 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.41x | 0.23x | 1.14x | 0.12x | 0.79x |
| Net DebtTotal debt minus cash | $916M | $65M | $353M | -$566M | $2.2B |
| Cash & Equiv.Liquid assets | $84M | $52M | $473M | $763M | $803M |
| Total DebtShort + long-term debt | $1000M | $117M | $826M | $197M | $3.0B |
| Interest CoverageEBIT ÷ Interest expense | 0.67x | 0.91x | 0.79x | 1.48x | 1.97x |
Total Returns (Dividends Reinvested)
Evenly matched — IBCP and MBWM each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MBWM five years ago would be worth $17,837 today (with dividends reinvested), compared to $7,178 for FFIN. Over the past 12 months, MBWM leads with a +23.6% total return vs CBSH's -13.9%. The 3-year compound annual growth rate (CAGR) favors IBCP at 32.1% vs CBSH's 6.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.0% | +7.2% | +10.1% | +8.5% | +1.0% |
| 1-Year ReturnPast 12 months | +12.9% | +12.6% | +23.6% | -3.2% | -13.9% |
| 3-Year ReturnCumulative with dividends | +71.8% | +130.6% | +127.3% | +29.1% | +20.2% |
| 5-Year ReturnCumulative with dividends | -1.8% | +63.7% | +78.4% | -28.2% | -12.9% |
| 10-Year ReturnCumulative with dividends | +106.2% | +184.6% | +178.2% | +145.4% | +103.4% |
| CAGR (3Y)Annualised 3-year return | +19.8% | +32.1% | +31.5% | +8.9% | +6.3% |
Risk & Volatility
Evenly matched — FRME and CBSH each lead in 1 of 2 comparable metrics.
Risk & Volatility
CBSH is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than FFIN's 0.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FRME currently trades 93.7% from its 52-week high vs CBSH's 79.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | 0.83x | 0.87x | 0.95x | 0.70x |
| 52-Week HighHighest price in past year | $43.23 | $37.39 | $55.77 | $38.74 | $66.35 |
| 52-Week LowLowest price in past year | $34.66 | $29.63 | $42.17 | $28.11 | $46.99 |
| % of 52W HighCurrent price vs 52-week peak | +93.7% | +90.8% | +93.3% | +83.6% | +79.1% |
| RSI (14)Momentum oscillator 0–100 | 56.3 | 50.6 | 53.1 | 58.2 | 61.7 |
| Avg Volume (50D)Average daily shares traded | 378K | 176K | 112K | 740K | 1.2M |
Analyst Outlook
FRME leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FRME as "Buy", IBCP as "Hold", MBWM as "Buy", FFIN as "Hold", CBSH as "Hold". Consensus price targets imply 21.2% upside for FFIN (target: $39) vs 9.6% for MBWM (target: $57). For income investors, FRME offers the higher dividend yield at 3.55% vs CBSH's 2.06%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $49.00 | $38.00 | $57.00 | $39.25 | $58.50 |
| # AnalystsCovering analysts | 11 | 7 | 7 | 15 | 15 |
| Dividend YieldAnnual dividend ÷ price | +3.5% | +3.0% | +2.8% | +2.2% | +2.1% |
| Dividend StreakConsecutive years of raises | 14 | 11 | 6 | 11 | 12 |
| Dividend / ShareAnnual DPS | $1.44 | $1.03 | $1.47 | $0.72 | $1.08 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.8% | +1.8% | 0.0% | 0.0% | +2.7% |
FFIN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MBWM leads in 1 (Valuation Metrics). 2 tied.
FRME vs IBCP vs MBWM vs FFIN vs CBSH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FRME or IBCP or MBWM or FFIN or CBSH a better buy right now?
For growth investors, First Financial Bankshares, Inc.
(FFIN) is the stronger pick with 18. 8% revenue growth year-over-year, versus -0. 3% for First Merchants Corporation (FRME). Mercantile Bank Corporation (MBWM) offers the better valuation at 9. 5x trailing P/E (9. 5x forward), making it the more compelling value choice. Analysts rate First Merchants Corporation (FRME) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FRME or IBCP or MBWM or FFIN or CBSH?
On trailing P/E, Mercantile Bank Corporation (MBWM) is the cheapest at 9.
5x versus First Financial Bankshares, Inc. at 20. 8x. On forward P/E, Mercantile Bank Corporation is actually cheaper at 9. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Mercantile Bank Corporation wins at 0. 63x versus First Financial Bankshares, Inc. 's 3. 05x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FRME or IBCP or MBWM or FFIN or CBSH?
Over the past 5 years, Mercantile Bank Corporation (MBWM) delivered a total return of +78.
4%, compared to -28. 2% for First Financial Bankshares, Inc. (FFIN). Over 10 years, the gap is even starker: IBCP returned +184. 6% versus CBSH's +103. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FRME or IBCP or MBWM or FFIN or CBSH?
By beta (market sensitivity over 5 years), Commerce Bancshares, Inc.
(CBSH) is the lower-risk stock at 0. 70β versus First Financial Bankshares, Inc. 's 0. 95β — meaning FFIN is approximately 36% more volatile than CBSH relative to the S&P 500. On balance sheet safety, First Financial Bankshares, Inc. (FFIN) carries a lower debt/equity ratio of 12% versus 114% for Mercantile Bank Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — FRME or IBCP or MBWM or FFIN or CBSH?
By revenue growth (latest reported year), First Financial Bankshares, Inc.
(FFIN) is pulling ahead at 18. 8% versus -0. 3% for First Merchants Corporation (FRME). On earnings-per-share growth, the picture is similar: First Merchants Corporation grew EPS 13. 8% year-over-year, compared to 3. 5% for Independent Bank Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FRME or IBCP or MBWM or FFIN or CBSH?
First Financial Bankshares, Inc.
(FFIN) is the more profitable company, earning 30. 2% net margin versus 21. 5% for First Merchants Corporation — meaning it keeps 30. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FFIN leads at 36. 8% versus 24. 7% for FRME. At the gross margin level — before operating expenses — CBSH leads at 80. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FRME or IBCP or MBWM or FFIN or CBSH more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Mercantile Bank Corporation (MBWM) is the more undervalued stock at a PEG of 0. 63x versus First Financial Bankshares, Inc. 's 3. 05x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Mercantile Bank Corporation (MBWM) trades at 9. 5x forward P/E versus 15. 9x for First Financial Bankshares, Inc. — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FFIN: 21. 2% to $39. 25.
08Which pays a better dividend — FRME or IBCP or MBWM or FFIN or CBSH?
All stocks in this comparison pay dividends.
First Merchants Corporation (FRME) offers the highest yield at 3. 5%, versus 2. 1% for Commerce Bancshares, Inc. (CBSH).
09Is FRME or IBCP or MBWM or FFIN or CBSH better for a retirement portfolio?
For long-horizon retirement investors, Commerce Bancshares, Inc.
(CBSH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 2. 1% yield, +103. 4% 10Y return). Both have compounded well over 10 years (CBSH: +103. 4%, FRME: +106. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FRME and IBCP and MBWM and FFIN and CBSH?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FRME is a small-cap deep-value stock; IBCP is a small-cap deep-value stock; MBWM is a small-cap deep-value stock; FFIN is a small-cap high-growth stock; CBSH is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.